Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Glencore Bets on China’s Aluminum Boom with Chuangxin Listing Investment November 14, 2025 Realigning Portfolio Allocation with Nicholas Mersch November 14, 2025 Senior Loan Facility Refinanced with Nebari November 14, 2025